Significant reductions seen for global distress index, psychological symptoms, physical symptoms of Memorial Symptom Assessment Scale
Impact of Pandemic Projected for U.S. Breast Cancer Mortality
Cumulative increase of 0.52 percent expected in breast cancer deaths by 2030 due to disruptions during the first six months of the pandemic
ASCO: COVID-19 Infections, Deaths Not Up With Breast Cancer Chemo
Risk for death following SARS-CoV-2 infection increased with advanced-stage disease, higher comorbidity, but not receipt of chemotherapy
Pediatric Oncology Services Disrupted During Pandemic
Newly diagnosed pediatric cancer cases decreased in 43 percent of centers; treatment abandonment increased in 34 percent
SARS-CoV-2 Infection Rate Low in Patients Receiving Antitumor Therapy
Less than 1 percent of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19